The CELLO trial: Protocol of a planned phase 4 study to assess the efficacy of Ocrelizumab in patients with radiologically isolated syndrome
- Resource Type
- Article
- Source
- In
Multiple Sclerosis and Related Disorders December 2022 68 - Subject
- Language
- ISSN
- 2211-0348